NEWSWIRE
2022 AHRMM Advisory Board announced
FAST STATS
Long-term symptoms associated with COVID-19 represent an emerging public health concern that is not well understood, according to the Centers for Disease Control and Prevention. A CDC survey of adults conducted April 9-23, 2021 produced the following numbers regarding the prevalence of the most commonly reported symptoms.
65.9 %
of respondents previously tested positive for COVID-19, and reported having experienced long-term symptoms associated with the virus.
3,135 is the number of survey respondents. All
reported having been tested for SARS-CoV-2 since January 2020, prior to the nationwide rollout of COVID-19 vaccines. None had been vaccinated, and all were over 18.
698
is the number of long-haul study subjects who had tested positive for COVID-19.
is the number of long haul study subjects who reported having testing negative for COVID-19.
2,437 22.9%
of the study group experienced fatigue four
weeks (or longer) after having tested positive for COVID-19.
17.3%
of the study group experienced change of smell or taste four weeks (or longer) after having tested positive for COVID-19.
15.5%
of the study group experienced shortness of breath four weeks (or longer) after having tested positive for COVID-19.
14.5%
of the study group experienced having a cough four weeks (or longer) after having tested positive for COVID-19.
Photo credit: Bihlmayerfotografi e |
stock.adobe.com 6
The Association for Health Care Resource & Materials Management (AHRMM) membership elected Maj Ricardo Alda- hondo, MBA, CMRP, medical operations planner at Headquarters United States Air Force, Pamela L. Bryant, BS, MBA, senior vice president and chief supply chain offi cer at Parkland Health Hospi- tal System, and d Hisscock, senior vice president of supply chain at Trinity Health as provider representatives on the 2022 advisory board. Aldahondo, Bryant and Hisscock will begin their advisory board terms on Janu- ary 1, 2022. The 2021 AHRMM Advisory Board elected Laura Kowalczyk, D, MPH, CMRP, vice president, supply chain and support services at UAB Medicine-The University of Alabama Birmingham as chair-elect of the 2022 advisory board. Kowalczyk will serve as advisory board
chair in 2023. Laura Kowalczyk is an executive with over 2 years of extensive legal, business and operational manage- ment experience in health care operations. She has had the opportunity to utilize her background and experience to foster the development and implementation of unique business strategies across the health care continuum. In her current role, Laura Kowalczyk is responsible for the strategic direction of UAB Medicine’s end-to-end Supply Chain, Environmental Services, Food and Nutrition Services, Guest Ser- vices, Patient Advocacy, Patient Transport, Spiritual Care and Clinical Ethics. As chair-elect, Kowalczyk intends to provide ongoing leadership that sup- ports the continued consistency necessary to foster the work that is being done to meet AHRMM’s goals, and the needs of AHRMM’s membership. Kowalczyk has been an AHRMM member since 2003. Maj Ricardo Aldahondo serves as a medical operations advisor and liaison to the Air Force Surgeon General at the Pentagon. Aldahondo has been with Headquarters United States Air Force since 2018. As a provider representative, Aldahondo will work to grow AHRMM’s military and civilian membership, pro- mote and invest in young professionals and maximize AHRMM’s potential to better position supply chain professionals to face the issues and successes of tomor- row. Aldahondo has been an AHRMM member since 2019.
A proven senior vice president and chief supply chain offi cer, Pamela L. Bryant is responsible for all aspects of the supply chain, including procurement, strategic sourcing, informatics, value analysis, sup-
October 2021 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
plier diversity, logistics, distribution, cus- tomer service, mailroom services, vendor management and equipment/asset man- agement. Bryant has been with Parkland Health & Hospital System since 2019. As a provider representative, Bryant will work to support local chapters to enhance their reach and sustainability. Bryant has been an AHRMM member since 2011. With 36 years of experience in health-
care, d Hisscock is currently the senior vice president of supply chain at Trinity Health where he has led the implemen- tation of an entirely new suite of supply chain applications and co-led the fi elds largest selfdistribution deployment and clinically driven supply chain initiative. Hisscock has been with Trinity Health since 201. As a provider representative, Hisscock will focus on growth strategies with, and through, the chapters and will advocate for the adoption of industry standards needed to improve supply chain resiliency on state and federal levels. Hisscock has been an AHRMM member since 2010.
Ed Hardin named 2021 Chuck Lauer Award winner at the Fall IDN Summit IDN executives, Suppliers and GPO part- ners safely gathered in Phoenix for the 2021 Fall IDN Summit August 30 - September 1. They celebrated Ed Hardin’s legacy as he was named the 2021 Chuck Lauer Award. After a lifetime of service to the health- care supply chain, Ed Hardin posthu- mously received the 2021 Chuck Lauer Award. d Hardin’s legacy was celebrated as a supply chain leader, an educator and mentor, a longtime IDN Summit Board Member, and, most importantly, and as a friend to many.
AMA releases 2022 CPT Code Set The annual update to the CPT code set incorporates a series of 1 vaccine-specifi c codes that are the model for effi ciently reporting and tracking immunizations and administrative services against the coronavirus (SARS-CoV-2). The work was initiated to meet the urgent public health need for streamlined reporting and track- ing of COVID-1 vaccinations is presented in a press release of the 2022 Current Procedural Terminology (CPT) code set published by the American Medical Asso- ciation (AMA). Working closely with the Centers for Disease Control and Prevention to develop vaccine-specifi c CPT codes, the AMA intro- duced the fi rst codes in the series for use in Nov. 2020 to clinically distinguish each
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
